3 forecasts for the PBM industry in 2022
Over the past two years, the global pandemic created significant changes in how we address access to and utilization of healthcare services. Implementing solutions to these evolving challenges can be costly. In fact, the Office of the Actuary at the federal Centers for Medicare and Medicaid Services (CMS) recently reported that U.S. healthcare spending rose to over $4 trillion in 2020 – the largest growth since 2002. And prescription drug spending alone increased 3% to $348.4 billion in 2020.
So what will the pharmacy benefit world look like in 2022? Will costs go down? Will PBMs take a more accountable and transparent approach to their pricing models? Here’s three forecasts that will impact the PBM industry this year.
Read more by clicking the link to the full article below.
View the Article Online
Associated People
